Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-04-11 @ 1:00 AM
Study NCT ID:
NCT00322556
Status:
COMPLETED
Last Update Posted:
2012-10-26
First Post:
2006-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
Sponsor:
CSL Behring
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZLB05_006CR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None